Intervention Review

Oxcarbazepine add-on for drug-resistant partial epilepsy

  1. Sergio M Castillo1,*,
  2. Dieter B Schmidt2,
  3. Sarah White3,
  4. Arif Shukralla4

Editorial Group: Cochrane Epilepsy Group

Published Online: 24 JUL 2000

Assessed as up-to-date: 26 MAR 2006

DOI: 10.1002/14651858.CD002028


How to Cite

Castillo SM, Schmidt DB, White S, Shukralla A. Oxcarbazepine add-on for drug-resistant partial epilepsy. Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002028. DOI: 10.1002/14651858.CD002028.

Author Information

  1. 1

    Hospital del Salvador, Servicio de Neurologia, Santiago, Chile

  2. 2

    Epilepsy Research Group, Berlin, Germany

  3. 3

    St Georges, University of London, Research Resource Unit, Department of Mental Health, London, UK

  4. 4

    Clinical Sciences Centre for Research and Education, University Department of Neurological Science, Liverpool, UK

*Sergio M Castillo, Servicio de Neurologia, Hospital del Salvador, Salvador 364, Providencia, Santiago, Chile. castillochile@yahoo.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JUL 2000

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.